Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating Crohn's disease or ulcerative colitis by administering inhibitors of tumor necrosis factor-like cytokine 1A (TL1A)

Methods of treating Crohn's disease or ulcerative colitis by administering inhibitors of tumor necrosis factor-like cytokine 1A (TL1A)

US Patent 11136386 · Granted Oct 5, 2021

Estimated economic value: $20,955,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Variants of TNFSF15 and DCR3 associated with Crohn's disease2025
Methods of treating refractory inflammatory disease using transcriptomic and gen2025
Methods of treating refractory inflammatory disease using transcriptomic and gen2025
Methods of selecting, based on polymorphisms, an inflammatory bowel disease subj2025
Methods of selecting, based on polymorphisms, an inflammatory bowel disease subj2025